Skip to main content
Clinical Trials/CTRI/2023/02/049395
CTRI/2023/02/049395
Not yet recruiting
未知

Intrathecal nalbuphine vs Buprenorphine as an adjuvant to Ropivacaine 0.75% heavy in lower limb orthopedic surgeries: A prospective randomized controlled study.

Shubham Jain0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: O- Medical and Surgical
Sponsor
Shubham Jain
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Shubham Jain

Eligibility Criteria

Inclusion Criteria

  • ASA physical I\-II

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials